Table 1 Relationship of NDUFS1 expression level with GC clinicopathological features.

From: Loss of NDUFS1 promotes gastric cancer progression by activating the mitochondrial ROS-HIF1α-FBLN5 signaling pathway

Variables

High NDUFS1 (n = 92)

Low NDUFS1 (n = 162)

P value

Sex

 Male

65

109

0.579

 Female

27

53

 

Age (years)

 <60

18

29

0.743

 ≥60

74

133

 

Tumor size (cm)

 <5

59

70

0.001*

 ≥5

33

92

 

Tumor differentiation

 Well and moderately differentiated

50

65

0.029*

 Poorly differentiated

42

97

 

Lymph node metastasis

 Absent

36

35

0.003*

 Present

56

127

 

TNM stage

 Early (I/II)

40

31

<0.001*

 Late (III/IV)

52

131

 
  1. *P < 0.05, Pearson’s χ2 test.
Back to article page